United States· US:24417-681_d8871970-cf1c-4cd2-86ed-0565c0dfb5cc

Ga-68-DOTATOC

A medicinal product containing edotreotide gallium ga-68, registered in United States by UIHC – P E T Imaging Center.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGa-68-DOTATOCATC—REGISTER NO.US:24417-681_d8871970…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EDOTREOTIDE GALLIUM GA-68
Manufacturer
UIHC – P E T Imaging Center
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    24417-681-30
  • ndc11
    2441768130
    14 mL in 1 VIAL, MULTI-DOSE (24417-681-30)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Edotreotide gallium ga-68 in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All edotreotide gallium ga-68 products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Austria · Sogacin
  • Germany · Tocscan
  • France · Sogacin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/57d9f712-365e-41e9-8c75-472c525b5d97
GET /v1/drugs/57d9f712-365e-41e9-8c75-472c525b5d97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "4",
  "substance": "EDOTREOTIDE GALLIUM GA-68",
  "productndc": "24417-681",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mCi/mL",
  "application_number": "NDA210828",
  "marketing_category": "NDA"
}

See everything about edotreotide gallium ga-68.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.